A new technology which dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by scientists at the University of York.
UC Berkeley and Nanyang Technological University, Singapore, aims to achieve new peaks in research excellence through collaboration in three research areas which are of significance globally - synthetic biology, stem cells and energy efficiency.
Science fiction fans still have another two months of waiting for the new Star Trek movie, but fans of actual science can feast their eyes now on the first movie ever of carbon atoms moving along the edge of a graphene crystal.
In response to the growth and development of nanotechnology companies that produce and use nanoscale materials, SOCMA's Nanotechnology SME Coalition has expanded its membership categories to address their specific needs.
Using aquatic microbes as their 'canary-in-a-cage', scientists from Ohio today reported that nanoparticles now being added to cosmetics, sunscreens, and hundreds of other personal care products may be harmful to the environment.
Researchers have successfully tested a system that can identify a piece of DNA's bases directly as it moves through a modified protein nanopore. With further development, this system could greatly reduce the expensive equipment, chemicals, and lab time needed for current scanning methods.
Investigators at the University of California, Riverside, have developed a simple and cost-effective method of building conducting polymer nanowires that can detect a wide range of levels of a cancer biomarker.
Using nanoparticles made of a biocompatible polymer, investigators were able to encapsulate a molecule isolated from green tea that triggers apoptosis and inhibits angiogenesis, two key biochemical events that could prevent cancer.
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it.